The novel therapy of tirzepatide peptide represents a significant advance in the management of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide targets two pathways – GLP-1 and GIP – resulting in https://tirzepatidepeptide689933.blogofchange.com/42751979/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment